Author

Anna A. Ascsillán

Semmelweis UniversityORCID 0000-0002-9415-6887Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aniel SáncheziD· 1 shared Áron BarthaiD· 1 shared Attila Marcell SzásziD· 1 shared Balázs GyőrffyiD· 1 shared Beáta SzeitziD· 1 shared Botond L. SzabolcsiD· 1 shared D. M. PaliD· 1 shared David FenyöiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aniel SánchezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction

Indira Plá, Botond L. Szabolcs, Petra Nikolett Péter, Zsuzsanna Újfaludi, Yonghyo Kim, Peter L. Horvatovich, Aniel Sánchez, Krzysztof Pawłowski, Elisabet Wieslander, Magdalena Kuras, Jimmy Rodriguez Murillo, Jéssica de Siqueira Guedes, D. M. Pal, Anna A. Ascsillán, Lazaro Hiram Betancourt, , Lajos Vince Kemény

This paper identifies potential drug targets and predicts treatment efficacy and resistance in melanoma subtypes using proteogenomic data and drug sensitivity analysis.

International Journal of Dermatology · Dec 25, 2024Peer-reviewedCancer Biology